Systembio Distributor

Bio-Compatibility and Bio-Insulation of Implantable Electrode Prosthesis Ameliorated by A-174 Silane Primed Parylene-C Deposited Embedment

Bio-Compatibility and Bio-Insulation of Implantable Electrode Prosthesis Ameliorated by A-174 Silane Primed Parylene-C Deposited Embedment

Bio-Compatibility and Bio-Insulation of Implantable Electrode Prosthesis Ameliorated by A-174 Silane Primed Parylene-C Deposited Embedment

Microelectrodes for ache administration, neural prosthesis or assistances have an enormous medical demand, similar to the applying of ache administration chip or retinal prosthesis addressed on age-related macular degeneration (AMD) and the retinitis pigmentosa (RP). As a consequence of lifelong implanted in human physique and direct adhesion of neural tissues, the electrodes and related insulation supplies ought to possess a great bio-compatibility, together with non-cytotoxicity and no security concern elicited by immune responses. Our objective meant to develop retinal prosthesis, {an electrical} circuit chip used for aiding neural electrons transmission on retina and ameliorating the retinal incapacity.

Subsequently, primarily based on the ISO 10993 steerage for implantable medical gadgets, the electrode prosthesis with insulation materials has to conduct bio-compatibility evaluation together with cytotoxicity, hemolysis, (pores and skin) irritation and pathological implantation examinations. On this research, we manufactured inter-digitated electrode (IDE) chips mimic the electrode prosthesis by photolithography. The titanium and platinum composites had been deposited onto a silicon wafer to organize an electrical circuit to imitate the electrode utilized in retinal prosthesis manufacture, which additional be encapsulated to look at the bio-compatibility in compliance with ISO 10993 and ASTM steerage particularly for implantable medical gadgets. Parylene-C, polyimide and silicon carbide had been chosen as supplies for electrode encapsulation compared.

Our information revealed parylene-C coating confirmed a major excellence on bio-insulation and bio-compatibility particularly addressed on implantable neuron stimulatory gadgets and supplied an financial process to bundle the electrode prosthesis. Subsequently, parylene C encapsulation ought to function a consideration for future software on retinal prosthesis manufacture and examination. Non-edible bio-oil derived from lignocellulosic biomass may very well be used as environmentally pleasant lubricant-ester base inventory for maritime and road-type transportations. Nonetheless, using crude bio-oil with extremely oxygenated compounds required additional upgrading to yield ester that mimicked the traits of Group V base oil (polyolesters). On this research, bio-oil primarily based polyolesters was produced by way of esterification utilizing inexperienced biopolymer alginate acid catalyst (Al-Alg).

 

Analysis of Bio-Mechanistic Habits of Liquid Self-Microemulsifying Drug Supply System in Biorelated Media

The intention of the research is to mechanistically examine the drug loci, structural integrity, chemical interactions, and absorption conduct of the liquid self-microemulsifying drug supply system (SMEDDS). The loci of drug molecules in self-forming microemulsions in biorelevant media (fasted state simulated gastric fluid and fed state simulated intestinal fluid) had been investigated by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy.
Chemical interactions had been noticed by attenuated complete reflectance spectroscopy (ATR). The structural integrity of self-forming microemulsions in biorelevant media was decided by small angle X-ray scattering (SAXS) and fluorescence resonance vitality switch (FRET). Morphological options of self-forming microemulsion had been decided by confocal laser scanning microscopy. In vitro, lipid digestion conduct was evaluated for particle measurement, zeta potential, free fatty acids (FFA), and drug launched by customary protocols. In-house characterizations had been decided by customary methodologies.
1H and 13C NMR revealed that drug loci had been present in a majority within the oily core area within the self-forming microemulsion. The ATR signifies that no inherent chemical was noticed within the liquid SMEDDS and drug-loaded self-microemulsions within the biorelevant media. Structural integrity was properly maintained through the dispersive and digestive phases within the gastrointestinal lumen throughout lipolysis in biorelevant circumstances, as revealed by SAXS and FRET. An in vitro digestion research in biorelevant circumstances depicts no fluctuations in measurement and zeta potential with a predominant launch of FFA and drug, and was to be revealed physiologically acceptable for medical functions.
 Bio-Compatibility and Bio-Insulation of Implantable Electrode Prosthesis Ameliorated by A-174 Silane Primed Parylene-C Deposited Embedment
Bio-Compatibility and Bio-Insulation of Implantable Electrode Prosthesis Ameliorated by A-174 Silane Primed Parylene-C Deposited Embedment

Stem cell progress and proliferation on RGD bio-conjugated cotton fibers

Background: Merging stem cells with biomimetic supplies symbolize a sexy strategy to tissue engineering. The event of an alternate scaffold with the flexibility to imitate the extracellular matrix, and the 3D gradient stopping any alteration in cell metabolism or of their gene expression patterns, would have many medical functions.
Goal: On this research, we launched using RGD (Arg-Gly-Asp) bio-conjugated cotton to advertise the expansion and proliferation of mesenchymal stem cells (MSCs).
Strategies: We measured the expression of stem cell markers and adhesion markers with Q-PCR and analyzed the transcriptomic. The outcomes obtained confirmed that the MSCs, when cultured with bio-conjugated cotton fibers, type aggregates across the fibers whereas proliferating. The seeded MSCs with cotton fibers proliferated in a similar way to the cells seeded on the monolayer (inhabitants doubling degree 1.88 and a pair of.19 respectively).
Outcomes: The entire genome sequencing of cells adhering to those cotton fibers and cells adhering to the cell tradition dish confirmed in a different way expressed genes and pathways in each populations. Nonetheless, the expression of the stem cell markers (Oct4, cKit, CD105) and cell adhesion markers (CD29, HSPG2 and CD138), when examined with quantitative RT-PCR, was maintained in each cell populations.

Bcl-xL Blocking Peptide

3312BP-50 each
EUR 183.6

Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide

M2E11-P 100 ug
EUR 196.8

Human, mouse, rat connexin 43 and 37 hemi-channel blocking peptide (GAP27 domain with conserved sequence SRPTEK)

Cx2703-P-1 1 mg
EUR 315.6

Human, mouse, rat connexin 43 and 37 hemi-channel blocking peptide (GAP27 domain with conserved sequence SRPTEK)

Cx2703-P-5 5 mg
EUR 927.6

Phospho-BCL-XL (Thr47) Blocking Peptide

AF3414-BP 1mg
EUR 234

Phospho-BCL-XL (Ser62) Blocking Peptide

AF3415-BP 1mg
EUR 234

BCL-3 Blocking Peptide

AF7756-BP 1mg
EUR 234

Bcl-2 Blocking Peptide

3033BP-50 each
EUR 183.6

Bcl-3 Blocking Peptide

3407BP-50 each
EUR 183.6

Bcl-6 Blocking Peptide

3408BP-50 each
EUR 183.6

Bcl-2 Blocking Peptide

BF9103-BP 1mg
EUR 234

BCL-2 Blocking Peptide

AF0769-BP 1mg
EUR 234

Bcl-2 Blocking Peptide

AF4700-BP 1mg
EUR 234

BCL-2 Blocking Peptide

AF6139-BP 1mg
EUR 234

BCL-3 Blocking Peptide

DF10317-BP 1mg
EUR 234

Bcl 6 Blocking Peptide

33R-10485 50 ug
EUR 418.8
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Bcl 6 antibody, catalog no. 20R-1556

Sequestosome 1 Blocking Peptide

33R-2383 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SQSTM1 antibody, catalog no. 70R-5720

Bcl-B Blocking Peptide

3695BP-50 each
EUR 183.6

Bcl-Rambo Blocking Peptide

3671BP-50 each
EUR 183.6

Erythropoietin Mimetic Peptide Sequence 20

H-4344.0001 1.0mg
EUR 544.8
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net

Erythropoietin Mimetic Peptide Sequence 20

H-4344.0005 5.0mg
EUR 2067.6
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net

Substance P reversed sequence Peptide

20-abx266314
  • EUR 594.00
  • EUR 978.00
  • EUR 427.20
  • 10 mg
  • 25 mg
  • 5 mg

Control/Blocking peptide Human BCL-2

BCL11-C 100 ug
EUR 196.8

Control/Blocking peptide Mouse BCL-2

BCL21-C 100 ug
EUR 196.8

EBFP antibody Blocking Peptide

BF0706-BP 1mg
EUR 234

LC3A antibody Blocking Peptide

BF0707-BP 1mg
EUR 234

PARP antibody Blocking Peptide

BF0719-BP 1mg
EUR 234

EYFP antibody Blocking Peptide

BF0725-BP 1mg
EUR 234

HSC70 antibody Blocking Peptide

BF0712-BP 1mg
EUR 234

Rubisco antibody Blocking Peptide

BF0726-BP 1mg
EUR 234

Rabbit Anti-Borrelia Vmp-like sequence expressed (VlsE) C6 peptide IgG, aff pure

VLSE61-A 100 ul
EUR 578.4

Transferrin antibody Blocking Peptide

BF0720-BP 1mg
EUR 234

BCL10 Blocking Peptide

DF6246-BP 1mg
EUR 234

BCL10 Blocking Peptide

DF3606-BP 1mg
EUR 234

Phospho-BCL-3 (Ser41) Blocking Peptide

AF7256-BP 1mg
EUR 234

Phospho-BCL-2 (Ser87) Blocking Peptide

AF3138-BP 1mg
EUR 234

Phospho-BCL-2 (Thr69) Blocking Peptide

AF3139-BP 1mg
EUR 234

Phospho-BCL-2 (Ser70) Blocking Peptide

AF3140-BP 1mg
EUR 234

Phospho-BCL-2 (Thr74) Blocking Peptide

AF8465-BP 1mg
EUR 234

Phospho-Bcl-2 (Thr56) Blocking Peptide

AF4400-BP 1mg
EUR 234

GSK3 beta antibody Blocking Peptide

BF0721-BP 1mg
EUR 234

HP1 gamma antibody Blocking Peptide

BF0723-BP 1mg
EUR 234

BCL2 Blocking Peptide

20-abx062289
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

Bcl2 Blocking Peptide

33R-10602 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Bcl2 antibody, catalog no. 70R-11571

BCL3 Blocking Peptide

33R-10746 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL3 antibody, catalog no. 70R-11804

BCL6 Blocking Peptide

33R-10747 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL6 antibody, catalog no. 70R-11805

BCL9 Blocking Peptide

DF12515-BP 1mg
EUR 234

Bcl6 Blocking Peptide

DF2903-BP 1mg
EUR 234

BCL6 Blocking Peptide

20-abx161029
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

BCL2 Blocking Peptide

20-abx161300
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

BCL6 Blocking Peptide

20-abx161304
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

BCL2 Blocking Peptide

20-abx161556
  • EUR 727.20
  • EUR 1713.60
  • 1 mg
  • 5 mg

BCL6 Blocking Peptide

20-abx162090
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

Phospho-Bcl-6 (Ser343) Blocking Peptide

AF8244-BP 1mg
EUR 234

Phospho-BCL-3 (Ser402) Blocking Peptide

AF8466-BP 1mg
EUR 234

BCL11A Blocking Peptide

AF7561-BP 1mg
EUR 234

BCL11A Blocking Peptide

33R-10043 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL11A antibody, catalog no. 70R-8372

BCL11A Blocking Peptide

33R-6490 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL11A antibody, catalog no. 70R-8336

BCL11A Blocking Peptide

DF7345-BP 1mg
EUR 234

BCL11B Blocking Peptide

DF2464-BP 1mg
EUR 234

Borrelia Vmp-like sequence expressed (VlsE) C6 peptide (>90%) for ELISA

VLSE65-UL 100 ug
EUR 416.4

BCL9L Blocking Peptide

AF7915-BP 1mg
EUR 234

BCL7A Blocking Peptide

33R-1704 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL7A antibody, catalog no. 70R-3771

BCL6B Blocking Peptide

33R-5338 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL6B antibody, catalog no. 70R-8459

BCL7A Blocking Peptide

33R-7534 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL7A antibody, catalog no. 70R-3765

BCL6B Blocking Peptide

DF9075-BP 1mg
EUR 234

BCL7A Blocking Peptide

DF4737-BP 1mg
EUR 234

BCL7B Blocking Peptide

DF2586-BP 1mg
EUR 234

BCL7C Blocking Peptide

DF2587-BP 1mg
EUR 234

Phospho-BCL-10 (Ser138) Blocking Peptide

AF8215-BP 1mg
EUR 234

Plant actin antibody Blocking Peptide

BF0710-BP 1mg
EUR 234

Histone H2B antibody Blocking Peptide

BF0722-BP 1mg
EUR 234

BCL2A1 Blocking Peptide

33R-2930 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL2A1 antibody, catalog no. 70R-10524

BCL2L1 Blocking Peptide

33R-8657 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL2L1 antibody, catalog no. 20R-1065

BCL2L1 Blocking Peptide

33R-5547 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL2L1 antibody, catalog no. 70R-10444

BCL2L1 Blocking Peptide

33R-6481 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL2L1 antibody, catalog no. 70R-10443

BCL2A1 Blocking Peptide

DF7652-BP 1mg
EUR 234

BCL2L1 Blocking Peptide

DF6015-BP 1mg
EUR 234

BCL2L2 Blocking Peptide

DF6292-BP 1mg
EUR 234

BCL2L13 Blocking Peptide

33R-9493 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL2L13 antibody, catalog no. 70R-10451

BCL2L12 Blocking Peptide

33R-4918 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL2L12 antibody, catalog no. 70R-10366

BCL2L14 Blocking Peptide

DF9220-BP 1mg
EUR 234

BCL2L12 Blocking Peptide

DF3830-BP 1mg
EUR 234

BCL2L13 Blocking Peptide

DF6248-BP 1mg
EUR 234

BCL2L10 Blocking Peptide

DF2276-BP 1mg
EUR 234

BCL2L13 Blocking Peptide

DF2649-BP 1mg
EUR 234

Cytochrome C antibody Blocking Peptide

BF0714-BP 1mg
EUR 234

BCLW Blocking Peptide

20-abx062039
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

BclB Blocking Peptide

33R-10884 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BclB antibody, catalog no. 70R-12009

BCLW Blocking Peptide

DF3607-BP 1mg
EUR 234

BCLX Blocking Peptide

20-abx161558
  • EUR 727.20
  • EUR 1713.60
  • 1 mg
  • 5 mg

Cyclophilin B antibody Blocking Peptide

BF0717-BP 1mg
EUR 234

Cytokeratin 18 antibody Blocking Peptide

BF0727-BP 1mg
EUR 234

BCLAF1 Blocking Peptide

20-abx063617
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

BCLAF1 Blocking Peptide

DF3828-BP 1mg
EUR 234

Beta II tubulin antibody Blocking Peptide

BF0716-BP 1mg
EUR 234

BCL2 (pT56) Blocking Peptide

20-abx061740
  • EUR 360.00
  • EUR 594.00
  • 1 mg
  • 5 mg

BCL2 (pS70) Blocking Peptide

20-abx061755
  • EUR 360.00
  • EUR 594.00
  • 1 mg
  • 5 mg

BCL2 (pS70) Blocking Peptide

20-abx062038
  • EUR 376.80
  • EUR 610.80
  • 1 mg
  • 5 mg

BCL2 (pT69) Blocking Peptide

20-abx062288
  • EUR 376.80
  • EUR 610.80
  • 1 mg
  • 5 mg

BCL2 (pS87) Blocking Peptide

20-abx161301
  • EUR 376.80
  • EUR 610.80
  • 1 mg
  • 5 mg

BCL6 (pS333) Blocking Peptide

20-abx161559
  • EUR 1062.00
  • EUR 2548.80
  • 1 mg
  • 5 mg

Borrelia Vmp-like sequence expressed (VlsE) C6 peptide-Biotin (>90%) for ELISA

VLSE65-BTN 100 ug
EUR 489.6

Cleaved Caspase 3 antibody Blocking Peptide

BF0711-BP 1mg
EUR 234

BCLX (pS62) Blocking Peptide

20-abx161302
  • EUR 376.80
  • EUR 610.80
  • 1 mg
  • 5 mg

BCLX (pT47) Blocking Peptide

20-abx161557
  • EUR 1062.00
  • EUR 2548.80
  • 1 mg
  • 5 mg

Control/Blocking peptide for Ephrin-B2 antibody

NIVE2B-C 100 ug
EUR 196.8

ANT4 Blocking Peptide

20-abx063996
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

ANT3 Blocking Peptide

20-abx062021
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

ANT2 Blocking Peptide

20-abx062242
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

ANTP Blocking Peptide

33R-7700 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Antp antibody, catalog no. 70R-2190

40787 Blocking Peptide

33R-2900 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEPT1 antibody, catalog no. 70R-9926

hCG_1982709 Blocking Peptide

33R-3437 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1982709 antibody, catalog no. 70R-9054

hCG_2042202 Blocking Peptide

33R-3770 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_2042202 antibody, catalog no. 70R-9063

hCG_1660138 Blocking Peptide

33R-4078 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1660138 antibody, catalog no. 70R-9044

hCG_1646157 Blocking Peptide

33R-4162 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1646157 antibody, catalog no. 70R-9034

hCG_20426 Blocking Peptide

33R-4753 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_20426 antibody, catalog no. 70R-8776

hCG_2007354 Blocking Peptide

33R-5366 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_2007354 antibody, catalog no. 70R-9061

hCG_20426 Blocking Peptide

33R-5875 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_20426 antibody, catalog no. 70R-8775

HCG_1745121 Blocking Peptide

33R-6558 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1745121 antibody, catalog no. 70R-3903

hCG_1646157 Blocking Peptide

33R-7420 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1646157 antibody, catalog no. 70R-9035

ANTXR1 Blocking Peptide

33R-9794 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ANTXR1 antibody, catalog no. 70R-7338

Antxr2 Blocking Peptide

33R-3429 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Antxr2 antibody, catalog no. 70R-8864

TK Blocking Peptide

AF7678-BP 1mg
EUR 234

Rb Blocking Peptide

AF7698-BP 1mg
EUR 234

T Blocking Peptide

BF0015-BP 1mg
EUR 234

A1 Blocking Peptide

3401BP-50 each
EUR 183.6

Ub Blocking Peptide

20-abx063395
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

E7 Blocking Peptide

BF0311-BP 1mg
EUR 234

AR Blocking Peptide

BF0418-BP 1mg
EUR 234

PR Blocking Peptide

BF0581-BP 1mg
EUR 234

RB Blocking Peptide

BF0614-BP 1mg
EUR 234

ER Blocking Peptide

BF0674-BP 1mg
EUR 234

GK Blocking Peptide

AF0829-BP 1mg
EUR 234

GR Blocking Peptide

AF5004-BP 1mg
EUR 234

GR Blocking Peptide

AF6066-BP 1mg
EUR 234

GR Blocking Peptide

AF6067-BP 1mg
EUR 234

TK Blocking Peptide

AF6068-BP 1mg
EUR 234

IR Blocking Peptide

AF6098-BP 1mg
EUR 234

IR Blocking Peptide

AF6099-BP 1mg
EUR 234

F7 Blocking Peptide

33R-1026 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DLG4 antibody, catalog no. 70R-4080

GC Blocking Peptide

33R-10350 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GC antibody, catalog no. 70R-10252

A1 Blocking Peptide

33R-10744 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of A1 antibody, catalog no. 70R-11802

KC Blocking Peptide

33R-11041 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KC antibody, catalog no. 70R-12298

F2 Blocking Peptide

33R-1783 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of F2 antibody, catalog no. 70R-8514

PB Blocking Peptide

33R-2067 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192

AC Blocking Peptide

33R-3003 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ac antibody, catalog no. 70R-1978

XK Blocking Peptide

33R-7655 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XK antibody, catalog no. 70R-7274

F7 Blocking Peptide

33R-7835 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of F7 antibody, catalog no. 70R-9970

PC Blocking Peptide

33R-8614 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PC antibody, catalog no. 70R-9828

TH Blocking Peptide

33R-3167 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TH antibody, catalog no. 70R-7854

F8 Blocking Peptide

33R-3569 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of F8 antibody, catalog no. 70R-9971

NP Blocking Peptide

33R-3631 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NP antibody, catalog no. 70R-2286

GC Blocking Peptide

33R-4418 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GC antibody, catalog no. 70R-10253

XK Blocking Peptide

33R-5017 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XK antibody, catalog no. 70R-7169

SI Blocking Peptide

33R-5258 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SI antibody, catalog no. 70R-7230

GK Blocking Peptide

33R-5595 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GK antibody, catalog no. 70R-4533

TH Blocking Peptide

33R-6309 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TH antibody, catalog no. 70R-10442

HB Blocking Peptide

33R-6336 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hb antibody, catalog no. 70R-3198

N Blocking Peptide

33R-6561 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LSM8 antibody, catalog no. 70R-4590

SI Blocking Peptide

33R-6891 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SI antibody, catalog no. 70R-7205

KC Blocking Peptide

5212BP-50 each
EUR 183.6

OR Blocking Peptide

DF10250-BP 1mg
EUR 234

CP Blocking Peptide

DF9369-BP 1mg
EUR 234
Conclusion: These outcomes clearly present the flexibility of the cotton fibers to advertise MSCs progress and proliferation in a 3D construction mimicking the in vivo surroundings with out dropping their stem cell phenotype.

Leave a Reply

Your email address will not be published.